skip to main content
Idioma:
Refinado por: assunto: Microbial Sensitivity Tests remover Journal Of Antimicrobial Chemotherapy remover assunto: Pharmacology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa

Aoki, Nobumasa ; Tateda, Kazuhiro ; Kikuchi, Yoshiaki ; Kimura, Soichiro ; Miyazaki, Choichiroh ; Ishii, Yoshikazu ; Tanabe, Yoshinari ; Gejyo, Fumitake ; Yamaguchi, Keizo

Journal of antimicrobial chemotherapy, 2009-03, Vol.63 (3), p.534-542 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
2
Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin
Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin

Arhin, Francis F. ; Sarmiento, Ingrid ; Parr, Thomas R. ; Moeck, Gregory

Journal of antimicrobial chemotherapy, 2009-10, Vol.64 (4), p.868-870 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
3
Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system
Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system

Bowker, Karen E. ; Noel, Alan R. ; MacGowan, Alasdair P.

Journal of antimicrobial chemotherapy, 2006-10, Vol.58 (4), p.802-805 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
4
Population pharmacokinetic/pharmacodynamic study suggests continuous infusion of ceftaroline daily dose in ventilated critical care patients with early-onset pneumonia and augmented renal clearance
Population pharmacokinetic/pharmacodynamic study suggests continuous infusion of ceftaroline daily dose in ventilated critical care patients with early-onset pneumonia and augmented renal clearance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Population pharmacokinetic/pharmacodynamic study suggests continuous infusion of ceftaroline daily dose in ventilated critical care patients with early-onset pneumonia and augmented renal clearance

Chauzy, Alexia ; Gregoire, Nicolas ; Ferrandière, Martine ; Lasocki, Sigismond ; Ashenoune, Karim ; Seguin, Philippe ; Boisson, Matthieu ; Couet, William ; Marchand, Sandrine ; Mimoz, Olivier ; Dahyot-Fizelier, Claire

Journal of antimicrobial chemotherapy, 2022-10, Vol.77 (11), p.3173-3179 [Periódico revisado por pares]

England: Oxford University Press (OUP)

Texto completo disponível

Citações Citado por
5
Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study
Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study

Denisuik, Andrew J ; Garbutt, Lauren A ; Golden, Alyssa R ; Adam, Heather J ; Baxter, Melanie ; Nichol, Kimberly A ; Lagacé-Wiens, Philippe ; Walkty, Andrew J ; Karlowsky, James A ; Hoban, Daryl J ; Mulvey, Michael R ; Zhanel, George G

Journal of antimicrobial chemotherapy, 2019-03, Vol.74 (3), p.645-653 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
6
In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004–05 Prospective European Surveillance Initiative
In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004–05 Prospective European Surveillance Initiative
Material Type:
Artigo 		Adicionar ao Meu Espaço

In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004–05 Prospective European Surveillance Initiative

Draghi, Deborah C. ; Benton, Bret M. ; Krause, Kevin M. ; Thornsberry, Clyde ; Pillar, Chris ; Sahm, Daniel F.

Journal of antimicrobial chemotherapy, 2008-07, Vol.62 (1), p.116-121 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
7
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

Karageorgopoulos, Drosos E. ; Kelesidis, Theodore ; Kelesidis, Iosif ; Falagas, Matthew E.

Journal of antimicrobial chemotherapy, 2008-07, Vol.62 (1), p.45-55 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
8
Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay
Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay
Material Type:
Artigo 		Adicionar ao Meu Espaço

Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay

Kuster, Stefan P. ; Ruef, Christian ; Zbinden, Reinhard ; Gottschalk, Jochen ; Ledergerber, Bruno ; Neuber, Lutz ; Weber, Rainer

Journal of antimicrobial chemotherapy, 2008-12, Vol.62 (6), p.1451-1461 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
9
Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus
Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus

Leonard, Steven N. ; Kaatz, Glenn W. ; Rucker, Latoyia R. ; Rybak, Michael J.

Journal of antimicrobial chemotherapy, 2008-12, Vol.62 (6), p.1305-1310 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
10
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes
Material Type:
Artigo 		Adicionar ao Meu Espaço

In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes

Mushtaq, Shazad ; Warner, Marina ; Ge, Yigong ; Kaniga, Koné ; Livermore, David M.

Journal of antimicrobial chemotherapy, 2007-08, Vol.60 (2), p.300-311 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.